2,4-PyriMidinediaMine, 5-[5-iodo-4-Methoxy-2-(1-Methylethyl)phenoxy]-
- CAS No.
- 865305-30-2
- Chemical Name:
- 2,4-PyriMidinediaMine, 5-[5-iodo-4-Methoxy-2-(1-Methylethyl)phenoxy]-
- Synonyms
- Ro 4;AF 353;CS-2469;CHEMBL526307;AF-353 (Ro-4);AF-353, 10 mM in DMSO;CHEMBL526307;AF 353;AF353;5-(5-iodo-4-methoxy-2-propan-2-ylphenoxy)pyrimidine-2,4-diamine;Ro4,inhibit,AF-353,P2X Receptor,Inhibitor,Ro 4,P2XRs,AF353,AF 353;5-[5-Iodo-4-methoxy-2-(1-methylethyl)phenoxy]-2,4-pyrimidinediamine
- CBNumber:
- CB72609596
- Molecular Formula:
- C14H17IN4O2
- Molecular Weight:
- 400.21
- MDL Number:
- MFCD18782750
- MOL File:
- 865305-30-2.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| Product description | Number | Pack Size | Price |
| AF-353 | 23034 | 1mg | $32 |
| AF-353 | 23034 | 5mg | $102 |
| AF-353 99.43% | CS-5061 | 5mg | $61 |
| AF 353 | BA165790 | 1mg | $250 |
| AF-353 99.43% | CS-5061 | 10mg | $97 |
| More product size | |||
| Boiling point | 510.2±60.0 °C(Predicted) |
|---|---|
| Density | 1.619±0.06 g/cm3(Predicted) |
| storage temp. | Store at -20°C |
| solubility | DMSO : ≥ 32 mg/mL (79.96 mM) |
| pka | 6.89±0.10(Predicted) |
| form | Solid |
| color | Light brown to brown |
| InChI | InChI=1S/C14H17IN4O2/c1-7(2)8-4-11(20-3)9(15)5-10(8)21-12-6-18-14(17)19-13(12)16/h4-7H,1-3H3,(H4,16,17,18,19) |
| InChIKey | AATPYXMXFBBKFO-UHFFFAOYSA-N |
| SMILES | C1(N)=NC=C(OC2=CC(I)=C(OC)C=C2C(C)C)C(N)=N1 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) | ![]() GHS07 |
|---|---|
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H335 |
| Precautionary statements | P261-P305+P351+P338 |
2,4-PyriMidinediaMine, 5-[5-iodo-4-Methoxy-2-(1-Methylethyl)phenoxy]- price More Price(30)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 23034 | AF-353 | 865305-30-2 | 1mg | $32 | 2022-04-27 | Buy |
| Cayman Chemical | 23034 | AF-353 | 865305-30-2 | 5mg | $102 | 2022-04-27 | Buy |
| ChemScene | CS-5061 | AF-353 99.43% | 865305-30-2 | 5mg | $61 | 2026-06-04 | Buy |
| Biosynth | BA165790 | AF 353 | 865305-30-2 | 1mg | $250 | 2026-06-04 | Buy |
| ChemScene | CS-5061 | AF-353 99.43% | 865305-30-2 | 10mg | $97 | 2026-06-04 | Buy |
2,4-PyriMidinediaMine, 5-[5-iodo-4-Methoxy-2-(1-Methylethyl)phenoxy]- Chemical Properties,Uses,Production
Description
AF-353 is a noncompetitive dual antagonist of the purinoreceptors P2X3 and P2X2/3 (IC50s = 10 and 79.4 nM, respectively). It is selective for P2X3 and P2X2/3 over P2X1, P2X2, P2X4, P2X5, and P2X7 (IC50 = >10 μM for all). It inhibits calcium flux in CHO-K1 cells expressing the rat P2X3 receptor and in 1321N1 cells expressing the human P2X3 and P2X2/3 receptors (IC50s = 8.91, 8.71, and 38.9 nM, respectively). AF-353 decreases the electrical signals in the detrusor, but not striated, muscle of the bladder in female rats.
Uses
AF-353 (Ro-4) is a potent, selective and orally bioavailable P2X3/P2X2/3 receptor antagonist, with a pIC50 of 8.0 for both human and rat P2X3, and with a pIC50 of 7.3 for human P2X2/3[1][2].
in vivo
AF-353 (Ro-4) does not compromise oxygen levels or cardiac function[2].
AF-353 (Ro-4) (10 mg/kg, 20 mg/kg; i.v.; for 4-6 hours) inhibits the purinergic response in both normal and spinal cord-injured (SCI) rats[2].
AF-353 (Ro-4) (10 mg/kg, 20 mg/kg; i.v.; for 4-6 hours) also reduces the inter-contractile interval in normal but not in SCI rats; however, the frequency of non-voiding (NVC) in SCI rats is significantly reduced[2].
| Animal Model: | Female Sprague-Dawley rats (250–300 g) bearing SCI[2] |
| Dosage: | 10 mg/kg, 20 mg/kg |
| Administration: | Intravenous injection; interval of 90 minutes, for 4 hours to 6 hours |
| Result: | Significantly reduced purinergic response in both normal and SCI rats. |
IC 50
P2X3 Receptor
References
[1] Gever JR, et al. AF-353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist. Br J Pharmacol. 2010 Jul;160(6):1387-1398. DOI:10.1111/j.1476-5381.2010.00796.x
[2] Munoz A, et al. Modulation of bladder afferent signals in normal and spinal cord-injured rats by purinergic P2X3 and P2X2/3receptors. BJU Int. 2012 Oct;110(8 Pt B):E409-414. DOI:10.1111/j.1464-410X.2012.11189.x
2,4-PyriMidinediaMine, 5-[5-iodo-4-Methoxy-2-(1-Methylethyl)phenoxy]- Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| TargetMol Chemicals Inc. | +1-781-999-5354; +1-00000000000 | marketing@targetmol.com | United States | 32431 | 58 |
| BOC Sciences | 16314854226; +8616314854226 | inquiry@bocsci.com | United States | 19852 | 58 |
| Zibo Hangyu Biotechnology Development Co., Ltd | +86-0533-2185556 +86-15965530500 | nickzhang@hangyubiotech.com | China | 9935 | 58 |
| HANGZHOU LEAP CHEM CO., LTD. | +86-571-87711850 +86-15355479329 | market18@leapchem.com | China | 43303 | 58 |
| Aladdin Scientific | tp@aladdinsci.com | United States | 54746 | 58 | |
| NANJING YINGWEN BIOTECHNOLOGY CO LTD | +86-13382787392 | sales@aeechem.com | China | 10000 | 58 |
| Amadis Chemical Company Limited | 571-89925085 | sales@amadischem.com | China | 131885 | 58 |
| Shanghai Jinyin Biological Technology Co., Ltd | 021-20986266 18019349802 | 814527417@qq.com | China | 461 | 58 |
| Chembest Research Laboratories Limited | 021-20908456 | sales@BioChemBest.com | China | 5996 | 61 |
| Shanghai Lollane Biological Technology Co.,Ltd. | 021-52996696,15000506266 15000506266 | China | 4857 | 55 |
View Lastest Price from 2,4-PyriMidinediaMine, 5-[5-iodo-4-Methoxy-2-(1-Methylethyl)phenoxy]- manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-07-14 | AF-353
865305-30-2
|
$42.00-153.00 | 99.35% | 10g | TargetMol Chemicals Inc. | ||
![]() |
2022-02-25 | af-353
865305-30-2
|
$100.00 | 1KG | 98% | 100KG | Hong Kong Tiansheng New Material Trading Co., Ltd | |
![]() |
2022-02-25 | af-353
865305-30-2
|
$100.00 | 1KG | 99% | 10kg | Hong Kong Tiansheng New Material Trading Co., Ltd |








